Two Phase 3 Trials of Dupilumab versus Placebo in Atopic DermatitisEric L. Simpson, Marius Ardeleanu, Bolanle Akinlade et al.|New England Journal of Medicine|2016Cited by 2k
Inefficacy of Immediate Node Dissection in Stage 1 Melanoma of the LimbsUmberto Veronesi, Robert Wagner, J Adamus et al.|New England Journal of Medicine|1977Cited by 667
Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*Andreas Wollenberg, Andrew Blauvelt, Emma Guttman‐Yassky et al.|British Journal of Dermatology|2020Cited by 590
Thin Stage I Primary Cutaneous Malignant MelanomaUmberto Veronesi, K. Wozniak, Natale Cascinelli et al.|New England Journal of Medicine|1988Cited by 564
Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremitiesUmberto Veronesi, Robert Wagner, J Adamus et al.|Cancer|1982Cited by 502